-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
Northrop Grumman Corporation (NOC) posted strong Q1 results with sales up 4.4% Y/Y to $9.9B (beating consensus by $125M) and EPS surging 85% Y/Y to $6.14 ($0.14 above consensus), primarily due to the absence of prior year's $477M B-21 loss provision. Aeronautics Systems swung from a $183M operating loss to $305M profit, reflecting operational recovery and B-21 production agreements. The quarter reinforced our view that NOC's performance is stabilizing following last year's B-21 charge, with underlying growth supported by program ramps across strategic deterrence and munitions. Management emphasized B-21 capacity expansion and reaffirmed 2026 FCF guidance of $3.1B-$3.5B, though it suspended buybacks to fund organic investments. We believe the $95.6B backlog provides multiyear revenue visibility, though execution risks remain on complex development programs. In our view, the company's growth trajectory depends heavily on B-21 production acceleration and Sentinel baseline stability over the next 12-18 months.